Ian Johnson


Ian has spent his business career in life science.  He was founder and CEO of Biotrace International plc, a listed company in which Harwood was a major holder of shares until its sale to 3M in December 2006.  Ian was non-executive chairman of two investments of Harwood Private Equity: Celsis Group (a public-to-private investment); and Cyprotex plc (a PIPE expansion-capital investment).

Ian studied at University College Cardiff obtaining an M.Sc. by thesis in Microbiology.  He is a chartered biologist, a member of the Institute of Biology and of the Institute of Directors, as well as being the author of numerous publications and patents in the field of rapid microbiological testing.

Back to Operational advisers